Category IP-Watch Briefs

UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India

The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments.

US Copyright Royalty Board Boosts Songwriters’ Streaming Pay Nearly 50%

Variety reports: The [US] Copyright Royalty Board has ruled to increase songwriter rates for interactive streaming by nearly 50% over the next five years, in a ruling issued early Saturday. Equally important, the CRB simplified and strengthened the manner in which songwriters are paid mechanical royalties, modifying terms in a way that offers a foothold in the free-market.

USPTO To Reveal New Design For Patents This Week

The United States Patent and Trademark Office (USPTO) will make public the new design for patents this week at the South by Southwest (SXSW) Interactive Festival in Austin, Texas. The new design will first be used on patent number 10 million, expected to issue this year. There have fewer than 12 basic design changes to the US patent since President George Washington granted the first patent in 1790, and only two in the last 100 years, USPTO said.